A team of researchers examined how the timing of a patient’s last dose of the treatment before total hip (THA) or total knee arthroplasty (TKA) can influence complications related to anesthesia, including delayed emergence, aspiration pneumonitis and conversion to intubation.
The study analyzed data from the TriNetX research network for patients who underwent THA or TKA between January 2018 and January 2023, comparing those halting GLP-1 agonists at different time intervals with a control